Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
45.3M
-
Shares change
-
+13.6M
-
Total reported value, excl. options
-
$513M
-
Value change
-
+$153M
-
Put/Call ratio
-
0.81
-
Number of buys
-
86
-
Number of sells
-
-47
-
Price
-
$11.33
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2021
160 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2021.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.3M shares
of 60M outstanding shares and own 75.4% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (9.9M shares), First Light Asset Management, LLC (3.47M shares), BlackRock Inc. (3.28M shares), STATE STREET CORP (3.13M shares), VANGUARD GROUP INC (2.7M shares), Woodline Partners LP (1.71M shares), Avidity Partners Management LP (1.45M shares), FMR LLC (1.2M shares), TWO SIGMA INVESTMENTS, LP (1.13M shares), and EAGLE ASSET MANAGEMENT INC (1.09M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.